Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (1), 29-52
- https://doi.org/10.1053/ctrv.1999.0144
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell linesSurgery, 1996
- TGF-β1 Overexpression in Murine Pancreas Induces Chronic Pancreatitis and Together with TNF-α, Triggers Insulin-Dependent DiabetesBiochemical and Biophysical Research Communications, 1995
- Oncogenes in cancer of the pancreasEuropean Journal of Surgical Oncology, 1995
- No standard treatment is available for advanced pancreatic cancerEuropean Journal Of Cancer, 1995
- The mitogen activated protein kinase signal transduction pathway: From the cell surface to the nucleusCellular Signalling, 1994
- DNA damage, oncogenesis and the p53 tumour-suppressor geneMutation Research, 1994
- Cripto, a member of the epidermal growth factor family, is over‐expressed in human pancreatic cancer and chronic pancreatitisInternational Journal of Cancer, 1994
- The epidermal growth factor receptor in human pancreatic cancerThe Journal of Pathology, 1992
- The p53 tumour suppressor geneNature, 1991
- Site‐selective 8‐chloroadenosine 3′,5′‐cyclic monophosphate inhibits transformation and transforming growth factor α production in Ki‐ras‐transformed rat fibroblastsFEBS Letters, 1989